文献速递前列腺增生与排尿功能障碍

行业付款与已发表的下尿路症状治疗器械使用立场之间的关联

Association between Industry Payments and Published Position on Use of Devices for the Treatment of Lower Urinary Tract Symptoms.
PubMed 文献 · Urology · 2021-11-06

该研究检索引用Urolift和Rezum关键试验的所有文章,由两名盲法泌尿外科医生将文章编码为支持或中立,并用Open Payments数据库记录作者从制造商处获得的付款。共纳入29篇文章、27名作者,其中20名(74%)接受过付款,多数(80%)未报告相关利益冲突;接受付款的作者更可能发表支持性文章(P = .014)。

要点

  • 27名作者中20名(74%)接受过器械制造商付款,多数未报告相关利益冲突。
  • 接受付款的作者发表支持性文章的比例更高(P = .014,卡方检验)。
  • 作者结论提示制造商付款与发表支持性立场之间可能存在关联。

核心结论

  • 这些数据提示制造商付款与作者对该制造商器械发表支持性立场之间存在关联。
  • 可能严重缺乏无财务利益冲突作者发表的社论文章。

研究设计与样本

  • 通过Google Scholar检索所有引用Urolift和Rezum各自关键试验的文章。
  • 由2名盲法泌尿外科医生将文章编码为支持或中立,另由一名盲法研究者从Open Payments Program数据库记录制造商付款。
  • 从235篇文章的初始筛选列表中识别出29篇文章,由27名唯一作者撰写。

主要发现

  • 29篇文章中15篇(52%)被编码为支持,14篇(48%)被编码为中立。
  • 27名作者中20名(74%)接受过器械制造商付款;自2014年以来,这些作者从NeoTract共获得270,000美元,从Boston Scientific共获得314,000美元。
  • 20名有付款的作者中9名(45%)从任一制造商获得超过10,000美元。
  • 有付款的作者中65%(13/20)仅发表支持性文章;有付款作者的文章贡献数是无付款作者的4倍以上(42 vs 10)。
  • 至少一篇支持性文章的作者比中立文章作者更可能接受器械制造商付款(P = .014,卡方检验)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the impact of industry payments to authors of opinion articles on the Urolift and Rezum devices. We also examined the extent to which authors omitted acknowledgements of financial conflicts-of-interest. METHODS: We searched Google Scholar for all articles that cite either of the respective pivotal trials for these devices. 2 blinded urologists coded the articles as favorable or neutral. A separate blinded researcher recorded industry payments from the manufacturers using the Open Payments Program database. RESULTS: We identified 29 articles written by 27 unique authors from an initial screening list of 235 articles. Of these articles, 15 (52%) were coded as positive and 14 (48%) were coded as neutral. 20 (74%) authors have accepted payments from the manufacturer of the device. Since 2014, these authors have collectively received $270,000 from NeoTract and $314,000 from Boston Scientific. Of the 20 authors with payments, 9 (45%) received more than $10,000 from either manufacturer. Of authors with payments, 65% (13/20) contributed to only positive articles. Authors who received payments had more than 4 times the number of article contributions than did authors without payments (42 vs 10). Authors of at least one favorable article were more likely to have received payments from the device manufacturers than authors of neutral articles (P = .014, Chi-squared test). Most (80%, 16/20) authors with payments did not report a relevant conflict-of-interest within any of their articles. CONCLUSION: These data suggest a relationship between payments from a manufacturer and positive published position on that company's device. There may be a critical lack of published editorial pieces by authors without financial conflicts of interest.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Singh A, Faris S, Agarwal P, et al. Association between Industry Payments and Published Position on Use of Devices for the Treatment of Lower Urinary Tract Symptoms. Urology. 2021. PMID: 34752849. doi:10.1016/j.urology.2021.10.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。